Lifecore Biomedical, Inc. (LFCR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Lifecore Biomedical, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -6.04x | 14.26x | -2.39x | -2.49x | -10.56x | -8.28x |
| P/B Ratio | 175.14x | 15.14x | -56.23x | 3.31x | 1.68x | 1.37x |
| P/S Ratio | 1.82x | 1.34x | 2.30x | 2.61x | 3.38x | 1.97x |
| Profitability | ||||||
| Gross Margin | 31.3% | 32.6% | 27.1% | 35.1% | 38.6% | 24.6% |
| Operating Margin | -13.4% | -6.9% | -21.1% | -10.6% | -8.7% | -16.2% |
| Net Margin | -30.0% | 9.4% | -96.4% | -104.9% | -32.0% | -23.9% |
| EBITDA Margin | -6.8% | 27.8% | -32.1% | 11.5% | -1.0% | -4.5% |
| Liquidity | ||||||
| Current Ratio | 2.84x | 2.08x | 2.39x | 0.66x | 1.46x | 0.96x |
| Quick Ratio | 1.77x | 1.06x | 1.35x | 0.46x | 0.84x | 0.55x |
| Leverage | ||||||
| Debt/Equity | 97.92x | 11.81x | -26.63x | 2.82x | 1.06x | 0.96x |
YoY = year-over-year change. Source: FMP..